GlassScriptPhysician profile
Brendan G Oconnell
NPI 1972763936
$3,346.06
in general payments reported to CMS, 2019-2025
11 companies · $1,344 in 2025
The $1,344 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2021: $422 · 2022: $947 · 2023: $14.76 · 2024: $265 · 2025: $1,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $862 · Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $861.72 |
| Food and Beverage | $761.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,065.28 | 2019-2025 | |
| Baxter Healthcare | $355.86 | 2019-2025 | Tisseel, Perclot |
| Ethicon US, LLC | $335.50 | 2021-2024 | Echelon Circular, Evarrest, Surgicel Nu-Knit |
| Medtronic, INC. | $214.71 | 2024-2025 | Signia |
| Covidien LP | $130.46 | 2019 | |
| Novo Nordisk INC | $108.59 | 2025 | |
| Ethicon INC. | $52.21 | 2019 | |
| Intra-Sana Laboratories | $29.52 | 2022-2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Madrigal Pharmaceuticals | $19.34 | 2025 | Rezdiffra |
| Lilly USA, LLC | $17.55 | 2025 | Zepbound |
| Standard Bariatrics, INC. | $17.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Oconnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.